Login
Home / PARD : OTC
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Poniard Pharmaceuticals, Inc.

$0 +$0.00 (+0.00%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0$0
Market Cap
150
AVG Volume
41
Trailing/Forward PE
-0/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
00.250.50.75109 Q209 Q309 Q410 Q110 Q210 Q310 Q411 Q111 Q211 Q3
Net Income (USD)
-15M-10M-5M009 Q209 Q309 Q410 Q110 Q210 Q310 Q411 Q111 Q211 Q3
Operating Income (USD)
-15M-10M-5M009 Q209 Q309 Q410 Q110 Q210 Q310 Q411 Q111 Q211 Q3
EBITDA (USD)
-15M-10M-5M009 Q209 Q309 Q410 Q110 Q210 Q310 Q411 Q111 Q211 Q3
Cash Flows (USD)
-10M-7.5M-5M-2.5M009 Q209 Q309 Q410 Q110 Q210 Q310 Q411 Q111 Q211 Q3
EPS (USD)
-15-10-5009 Q209 Q309 Q410 Q110 Q210 Q310 Q411 Q111 Q211 Q3
Expenses (USD)
05M10M15MR&DSG&ACapex09 Q209 Q309 Q410 Q110 Q210 Q310 Q411 Q111 Q211 Q3
Cash & Debt (USD)
020M40M60MCashLong Term DebtShort Term Debt09 Q209 Q309 Q410 Q110 Q210 Q310 Q411 Q111 Q211 Q3
Debt ratios
00.20.40.60.809 Q209 Q309 Q410 Q110 Q210 Q310 Q411 Q111 Q211 Q3
Margins
0%50%100%150%03 Q103 Q203 Q304 Q104 Q204 Q304 Q405 Q205 Q305 Q4
Return on Capital
-150%-100%-50%0%09 Q209 Q309 Q410 Q110 Q210 Q310 Q411 Q111 Q211 Q3
Shares Outstanding
0500K1M1.5M09 Q209 Q309 Q410 Q110 Q210 Q310 Q411 Q111 Q211 Q3
Book Value Per Share (USD)
01020304009 Q209 Q309 Q410 Q110 Q210 Q310 Q411 Q111 Q211 Q3
Total Assets (USD)
020M40M60M09 Q209 Q309 Q410 Q110 Q210 Q310 Q411 Q111 Q211 Q3
PE Ratio
25303540med 31.34Jan 04Jan 04Jan 04Feb 04Feb 04Mar 04Mar 04
Free Cash Flow Yield
-80000000%-60000000%-40000000%-20000000%0%med -6985017.06%Jan 25May 25Sep 25Jan 26May 26Sep 26
Price to Sales
01000200030004000med 836.72Jul 05Oct 05Feb 06May 06Sep 06Dec 06Mar 07
EV/EBITDA
5678910med 6.99Jan 04Jan 04Jan 04Feb 04Feb 04Mar 04Mar 04
Price/Operating Cashflow
01020304050med 21.93Oct 03Nov 03Dec 03Jan 04Jan 04Feb 04Mar 04
Price to Book
0000med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Poniard Pharmaceuticals, Inc.
PARD
Stockpicker

Video analysis: PARD

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.